Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 6, Number 6—December 2000

Research

Predominance of HIV-1 Subtype A and D Infections in Uganda

Dale J. Hu*Comments to Author , James Baggs†, Robert G. Downing*†, Danuta Pieniazek*, Jonathan Dorn*, Carol Fridlund*, Benon Biryahwaho‡, Sylvester D.K. Sempala‡, Mark A. Rayfield*, Timothy J. Dondero*, and Renu Lal*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †State of Washington, Department of Labor and Industries, Olympia, Washington; ‡Uganda Virus Research Institute/Centers for Disease Control and Prevention Research Collaboration, Uganda Virus Research Institute, Entebbe, Uganda

Main Article

Table 3

Clinical characteristics among a subset of persons infected with HIV-1 subtype A or Da

Characteristic Subtype A Subtype D p value
WHOa clinical stage n=37 n=46
1 or 2 8% 9% p=0.97
3 57% 54%
4 (AIDS) 35% 37%
CD4 n=29 n=26
Mean 253 187 p=0.24
Range 19-1,061 2-713
CD8 n=29 n=26
Mean 812 734 p=0.45
Range 288-2,000 139-1,458

aWHO = World Health Organization.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO